John Bradley Holcomb serves as Executive at MiNK Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John Bradley Holcomb has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 1, 2025 involved receiving (via award) 1,128 shares valued at $12.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 1, 2025 | INKT | $12.5K | Award | 1,128 | $11.09 | Discretionary |
John Bradley Holcomb currently holds 1,128 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Bradley Holcomb has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
John Bradley Holcomb's most recent insider trade was on Dec 1, 2025, when they sold 1,128 shares at $11.09 per share.
Get notified when new Form 4 filings are submitted